These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

378 related articles for article (PubMed ID: 30739869)

  • 1. Resolving the Paradox of Hepatic Insulin Resistance.
    Santoleri D; Titchenell PM
    Cell Mol Gastroenterol Hepatol; 2019; 7(2):447-456. PubMed ID: 30739869
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Unraveling the Regulation of Hepatic Metabolism by Insulin.
    Titchenell PM; Lazar MA; Birnbaum MJ
    Trends Endocrinol Metab; 2017 Jul; 28(7):497-505. PubMed ID: 28416361
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Hepatic selective insulin resistance at the intersection of insulin signaling and metabolic dysfunction-associated steatotic liver disease.
    Bo T; Gao L; Yao Z; Shao S; Wang X; Proud CG; Zhao J
    Cell Metab; 2024 May; 36(5):947-968. PubMed ID: 38718757
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Pathogenesis of selective insulin resistance in isolated hepatocytes.
    Cook JR; Langlet F; Kido Y; Accili D
    J Biol Chem; 2015 May; 290(22):13972-80. PubMed ID: 25873396
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Pathway-selective insulin resistance and metabolic disease: the importance of nutrient flux.
    Otero YF; Stafford JM; McGuinness OP
    J Biol Chem; 2014 Jul; 289(30):20462-9. PubMed ID: 24907277
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Zonation of glucose and fatty acid metabolism in the liver: mechanism and metabolic consequences.
    Hijmans BS; Grefhorst A; Oosterveer MH; Groen AK
    Biochimie; 2014 Jan; 96():121-9. PubMed ID: 23792151
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Insulin-sensitive protein kinases (atypical protein kinase C and protein kinase B/Akt): actions and defects in obesity and type II diabetes.
    Farese RV; Sajan MP; Standaert ML
    Exp Biol Med (Maywood); 2005 Oct; 230(9):593-605. PubMed ID: 16179727
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Metabolism and insulin signaling in common metabolic disorders and inherited insulin resistance.
    Højlund K
    Dan Med J; 2014 Jul; 61(7):B4890. PubMed ID: 25123125
    [TBL] [Abstract][Full Text] [Related]  

  • 9. MicroRNA-206 prevents hepatosteatosis and hyperglycemia by facilitating insulin signaling and impairing lipogenesis.
    Wu H; Zhang T; Pan F; Steer CJ; Li Z; Chen X; Song G
    J Hepatol; 2017 Apr; 66(4):816-824. PubMed ID: 28025059
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Insulin resistance in the liver: deficiency or excess of insulin?
    Bazotte RB; Silva LG; Schiavon FP
    Cell Cycle; 2014; 13(16):2494-500. PubMed ID: 25486190
    [TBL] [Abstract][Full Text] [Related]  

  • 11. The pathogenesis of insulin resistance: integrating signaling pathways and substrate flux.
    Samuel VT; Shulman GI
    J Clin Invest; 2016 Jan; 126(1):12-22. PubMed ID: 26727229
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Direct Hepatocyte Insulin Signaling Is Required for Lipogenesis but Is Dispensable for the Suppression of Glucose Production.
    Titchenell PM; Quinn WJ; Lu M; Chu Q; Lu W; Li C; Chen H; Monks BR; Chen J; Rabinowitz JD; Birnbaum MJ
    Cell Metab; 2016 Jun; 23(6):1154-1166. PubMed ID: 27238637
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Insulin signaling is required for insulin's direct and indirect action on hepatic glucose production.
    Fisher SJ; Kahn CR
    J Clin Invest; 2003 Feb; 111(4):463-8. PubMed ID: 12588884
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Insulin-independent regulation of hepatic triglyceride synthesis by fatty acids.
    Vatner DF; Majumdar SK; Kumashiro N; Petersen MC; Rahimi Y; Gattu AK; Bears M; Camporez JP; Cline GW; Jurczak MJ; Samuel VT; Shulman GI
    Proc Natl Acad Sci U S A; 2015 Jan; 112(4):1143-8. PubMed ID: 25564660
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Selective hepatic insulin resistance, VLDL overproduction, and hypertriglyceridemia.
    Sparks JD; Sparks CE; Adeli K
    Arterioscler Thromb Vasc Biol; 2012 Sep; 32(9):2104-12. PubMed ID: 22796579
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Irisin ameliorates hepatic glucose/lipid metabolism and enhances cell survival in insulin-resistant human HepG2 cells through adenosine monophosphate-activated protein kinase signaling.
    So WY; Leung PS
    Int J Biochem Cell Biol; 2016 Sep; 78():237-247. PubMed ID: 27452313
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Long Noncoding RNA lncSHGL Recruits hnRNPA1 to Suppress Hepatic Gluconeogenesis and Lipogenesis.
    Wang J; Yang W; Chen Z; Chen J; Meng Y; Feng B; Sun L; Dou L; Li J; Cui Q; Yang J
    Diabetes; 2018 Apr; 67(4):581-593. PubMed ID: 29382663
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Insulin signaling to hepatic lipid metabolism in health and disease.
    Leavens KF; Birnbaum MJ
    Crit Rev Biochem Mol Biol; 2011 Jun; 46(3):200-15. PubMed ID: 21599535
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Effects of hepatic protein tyrosine phosphatase 1B and methionine restriction on hepatic and whole-body glucose and lipid metabolism in mice.
    Lees EK; Krol E; Shearer K; Mody N; Gettys TW; Delibegovic M
    Metabolism; 2015 Feb; 64(2):305-14. PubMed ID: 25468142
    [TBL] [Abstract][Full Text] [Related]  

  • 20. New concepts in extracellular signaling for insulin action: the single gateway hypothesis.
    Bergman RN
    Recent Prog Horm Res; 1997; 52():359-85; discussion 385-7. PubMed ID: 9238859
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 19.